![Nassim Usman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nassim Usman
Directeur Général chez
Totus Medicines, Inc.
Profil
Nassim Usman is currently President, Chief Executive Officer & Director at Totus Medicines, Inc. and Independent Director at LifeSci Acquisition III Corp.
Former roles include President, Chief Executive Officer & Director at Catalyst Biosciences, Inc. until 2023, Chief Executive Officer & Director at Catalyst Bioscience, Inc. from 2011 to 2015, Independent Director at Gyre Therapeutics, Inc. from 2023 to 2024, Chief Operating Officer & Senior Vice President at Sirna Therapeutics, Inc. from 2004 to 2005, Director positions at Archemix Corp., Principia Biopharma, Inc., Mosaic Biosciences, Inc., TME Pharma AG, Atugen AG, and Osprey Pharmaceuticals Ltd., Principal at Phio Pharmaceuticals Corp., and Venture Partner at LSV Capital Management LLC.
Education includes undergraduate and doctorate degrees from McGill University.
Postes actifs de Nassim Usman
| Sociétés | Poste | Début |
|---|---|---|
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs for cancer patients | Directeur Général | 15/12/2023 |
Anciens postes connus de Nassim Usman
| Sociétés | Poste | Fin |
|---|---|---|
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Directeur Général | 01/08/2015 |
Osprey Pharmaceuticals Ltd.
 Osprey Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Develops a series of proprietary therapeutic drugs | Directeur/Membre du Conseil | 29/06/2012 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Directeur des opérations | 01/01/2005 |
| CATALYST BIOSCIENCES | Directeur Général | 30/10/2023 |
Formation de Nassim Usman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Commercial Services |
Catalyst Bioscience, Inc. /Old/
Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Osprey Pharmaceuticals Ltd.
Osprey Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Develops a series of proprietary therapeutic drugs | Health Technology |
Phio Pharmaceuticals Corp.
 Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Totus Medicines, Inc.
Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs for cancer patients | Health Technology |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
